Efficacy of 3D-MR mammography for breast conserving surgery after neoadjuvant chemotherapy
- 1 January 2002
- journal article
- research article
- Published by Springer Nature in Breast Cancer
- Vol. 9 (1) , 15-19
- https://doi.org/10.1007/bf02967541
Abstract
One of the main roles of neoadjuvant chemotherapy for breast cancer is to shrink large tumors to increase patient eligibility for breast conserving surgery. Three dimensional MR Mammography (3D-MRM) can detect tumor extension more accurately compared with mammography and Ultrasonography (US). Therefore, the shrinkage pattern observed on 3D-MRM was analyzed with regard to several pathological factors.Keywords
This publication has 16 references indexed in Scilit:
- The evidence-based use of induction chemotherapy in Breast CancerBreast Cancer, 2001
- Locally Advanced Breast Cancer Treated with Primary Chemotherapy: Comparison between Magnetic Resonance Imaging and Pathologic Evaluation of Residual DiseaseTumori Journal, 1999
- Neoadjuvant Chemotherapy, Locally Advanced Breast Cancer, and Quality of LifeJournal of Clinical Oncology, 1999
- Utility of Magnetic Resonance Imaging in the Management of Breast Cancer: Evidence for Improved Preoperative StagingJournal of Clinical Oncology, 1999
- Breast magnetic resonance imagingSeminars in Ultrasound, CT and MRI, 1998
- Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imagingCancer, 1996
- MR imaging of the breast.Radiology, 1995
- MR imaging of the breast: current status and future potential.American Journal of Roentgenology, 1994
- Local Failure and Margin Status in Early-Stage Breast Carcinoma Treated with Conservation Surgery and Radiation TherapyAnnals of Surgery, 1993
- Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Work in progress.Radiology, 1991